Su Nandar Aung - Infectious Diseases

Author Information

Su Nandar Aung is a researcher affiliated with the Division of Infectious Diseases at Brown University Alpert Medical School in Providence, Rhode Island, United States of America. Her work primarily focuses on infectious diseases, with a particular emphasis on HIV/AIDS and COVID-19. Her affiliation with a prestigious institution like Brown University underscores her involvement in significant research within the field of infectious diseases.

Research Contributions

Su Nandar Aung has made substantial contributions to the field of infectious diseases through her research on HIV/AIDS and COVID-19. Her studies have explored critical issues such as drug resistance in HIV-1, stigma and adherence to antiretroviral therapy in Myanmar, and the impact of peer counseling on HIV patients. Additionally, she has investigated the clinical experiences of SARS-CoV-2 and HIV coinfection, evaluated treatments for COVID-19, and reviewed predictors of COVID-19 severity. Her work is characterized by a blend of clinical insights and public health perspectives, aiming to improve treatment outcomes and understand the barriers in infectious disease management.

Aliases

Throughout her career, Su Nandar Aung has been known by several aliases, including Su Aung and Su N Aung. These variations in her name might appear in different publications or citations.

Publication and Citation Metrics

Metric	Value
Total Papers Published	15
Total Citation Count	767
H-index	6

Publications:

Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USA

DOI: 10.1093/ofid/ofab587

Year: 2022

Stigma Determines Antiretroviral Adherence in Adults With HIV in Myanmar

DOI: 10.1097/QAI.0000000000002813

Year: 2021

Evaluation of peer-to-peer HIV counseling in Myanmar: a measure of knowledge, adherence, and barriers.

DOI: 10.1080/09540121.2021.1902929

Year: 2021

Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study

DOI: 10.1016/j.jgar.2020.07.018

Year: 2020

Evaluating HIV Viral Rebound Among Persons on Suppressive Antiretroviral Treatment in the Era of “Undetectable Equals Untransmittable (U = U)”

DOI: 10.1093/ofid/ofaa529

Year: 2020

SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States

DOI: 10.1002/jia2.25573

Year: 2020

Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience

DOI: 10.1093/ofid/ofaa319

Year: 2020

COVID-19 in a Patient Presenting with Syncope and a Normal Chest X-ray.

DOI:

Year: 2020

Predictors of COVID‐19 severity: A literature review

DOI: 10.1002/rmv.2146

Year: 2020

Rapid Reversal of Complete Binocular Blindness With High-Dose Corticosteroids and Lumbar Drain in a Solid Organ Transplant Recipient With Cryptococcal Meningitis and Immune Reconstitution Syndrome: First Case Study and Literature Review

DOI: 10.1093/ofid/ofy007

Year: 2018

What should be done if a condom fails?

What is the Treatment for Rabies?

How do socio-economic factors influence the spread of infectious diseases?

How to Apply Insect Repellent Effectively?

How is Ebola Diagnosed?

How Does the Immune System Respond to Infections?

How Can HIV/AIDS Be Prevented?

What Challenges Exist in Targeting Structural Proteins?

Can Respiratory Symptoms Be Prevented?

What are the Criteria for Eradication?

Partnered Content Networks

Relevant Topics